4//SEC Filing
Ohr Pharmaceutical Inc 4
Accession 0001387131-14-003245
CIK 0001173281operating
Filed
Sep 9, 8:00 PM ET
Accepted
Sep 10, 5:56 PM ET
Size
8.2 KB
Accession
0001387131-14-003245
Insider Transaction Report
Form 4
HIRSCHMAN ORIN
Director10% Owner
Transactions
- Conversion
Common Stock, $0.0001 par value
2014-09-08$6.75/sh+71,888$485,244→ 1,750,748 total(indirect: See) - Conversion
Warrant
2014-09-08−337,481→ 129,000 total(indirect: See)Exercise: $6.75From: 2013-04-18Exp: 2014-09-30→ Common Stock (337,481 underlying)
Footnotes (5)
- [F1]The shares were acquired by the cashless exercise of warrants having an exercise price of $6.75 per share.
- [F2]Includes options and warrants.
- [F3]AIGH Investment Partners (AIGH) directly owns shares and warrants to purchase common stock. Mr. Hirschman is the sole member of AIGH and directly determines investment and voting decisions. Mr. Hirschman indirectly owns shares as custodian of accounts for the benefit of his minor children. Mr. Hirschman also owns options directly.
- [F4]Includes options owned by Mr. Hirschman and warrants to purchase common stock owned by AIGH.
- [F5]AIGH directly owns warrants to purchase common stock. Mr. Hirschman is the sole member of AIGH and directly determines investment and voting decisions.
Documents
Issuer
Ohr Pharmaceutical Inc
CIK 0001173281
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001173281
Filing Metadata
- Form type
- 4
- Filed
- Sep 9, 8:00 PM ET
- Accepted
- Sep 10, 5:56 PM ET
- Size
- 8.2 KB